Jorma Sormunen

Benzene exposure at workplace and risk of colorectal cancer in four Nordic countries

Madar Talibov, Jorma Sormunen, Johnni Hansen et al. · Cancer Epidemiology · 2018 · 52 citations · Full text

Pharmacy, Oncology, Toxicology +16

Lifetime physical activity and cancer incidence—A cohort study of male former elite athletes in Finland

Jorma Sormunen, Heli Bäckmand, Seppo Sarna et al. · Journal of science and medicine in sport · 2013 · 44 citations · Full text

Medicine, Oncology, Sports Medicine +14

Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial

Santeri A. Pakola, Katriina Peltola, James H.A. Clubb et al. · Clinical Cancer Research · 2024 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17

The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial

Matthew S. Block, James H.A. Clubb, Johanna Mäenpää et al. · Nature Communications · 2025 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Radium‐223 dichloride treatment in metastatic castration‐resistant prostate cancer in Finland: A real‐world evidence multicenter study

Anniina Hyväkkä, Okko‐Sakari Kääriäinen, Tapio Utriainen et al. · Cancer Medicine · 2022 · 21 citations · Full text

Medicine, Oncology, Urology +17